Skip to main content
ELV
NYSE Finance

Elevance Health lifts 2026 adjusted EPS guidance to at least $27.00 after a strong Q2 beat

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Financial
Sentiment info
Positive
Importance info
8
Price
$427
Mkt Cap
$92.683B
52W Low
$273.71
52W High
$436.24
52W Position info
56% above low
Off High info
2.1% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

ELV sits 56% above its 52-week low of $273.71.

Summary

Elevance Health posted Q2 2026 adjusted EPS of $7.45, beating estimates, and raised its full-year adjusted EPS guidance to at least $27.00. The company also lifted its operating cash flow outlook to at least $6.0 billion.


Key Events · Earnings and Guidance · ELV

  • Q2 Adjusted EPS Beats at $7.45

    Adjusted diluted EPS came in at $7.45, exceeding expectations, thanks to favorable benefit expense performance and a net below-the-line benefit of approximately $0.80 per share.

  • Full-Year Adjusted EPS Guidance Raised to at Least $27.00

    Reflecting strong second-quarter operating results, management raised its 2026 adjusted diluted EPS guidance to at least $27.00, up from a prior view that had already been lifted in April.

  • Operating Cash Flow Guidance Raised to at Least $6.0 Billion

    Full-year 2026 operating cash flow guidance was raised to at least $6.0 billion, up from prior expectations, driven by underlying business strength and the timing of a state Medicaid pass-through payment.

  • Share Repurchases and Dividend

    During Q2 2026, the company repurchased 0.7 million shares for $234 million at a weighted average price of $344.62, and declared a quarterly dividend of $1.72 per share.


Analysis · ELV · Finance

A standout Q2 adjusted EPS of $7.45, well ahead of expectations, prompted Elevance Health to raise its full-year 2026 adjusted EPS guidance to at least $27.00 — up from a prior view that had already been lifted in April. The outperformance was fueled by favorable benefit expense trends and a net below-the-line benefit of approximately $0.80 per share. Operating revenue edged up to $49.8 billion, though operating margin narrowed year-over-year as targeted investments and elevated medical costs in Government businesses weighed. In a further show of confidence, the company raised its operating cash flow guidance to at least $6.0 billion, underscoring robust underlying cash generation. This marks the second guidance increase this year and bolsters management's path toward returning to at least 12% adjusted EPS growth in 2027.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ELV was trading at $427.00 on NYSE in the Finance sector, with a market capitalization of approximately $92.7B. The 52-week trading range was $273.71 to $436.24. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ELV - Latest Insights

ELV
Nov 05, 2026, 1:13 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $426.93
Real-time Price: $442.00 info
Change: +$15.07 (+4%) info
Market Cap: $92.837B info
ELV
Oct 21, 2026, 2:14 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $441.36
Real-time Price: $442.00 info
Change: +$0.640 (+0.15%) info
Market Cap: $92.837B info
ELV
Oct 21, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $450.00
Real-time Price: $442.00 info
Change: -$8.00 (-2%) info
Market Cap: $92.837B info
ELV
Oct 21, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $439.00
Real-time Price: $442.00 info
Change: +$3.00 (+0.68%) info
Market Cap: $92.837B info
ELV
Jul 15, 2026, 11:27 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $387.70
Real-time Price: $442.00 info
Change: +$54.30 (+14%) info
Market Cap: $92.837B info